A Single Centre Study to Evaluate the Safety and Immunogenicity of the Human Papillomavirus Vaccine (GSK-580299) in Chinese Females

Clinical trial NCT00549900 · COMPLETED

Trial details

NCT number: NCT00549900
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Infections, Papillomavirus

Start date: 2007-12-02
Primary completion: 2008-07-12
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.